The First Affiliated Hospital Of Xinxiang Medical College

This study tests a new nasal spray for adults with chronic sinusitis. The spray turns into a gel inside the nose and releases three active ingredients: stem cell exosomes to help repair the nasal lining, an antihistamine to reduce inflammation, and an antiviral agent. The goal is…

This early-stage trial tests a nasal spray for adults with chronic sinusitis (without polyps). The spray contains stem cell exosomes to heal the nose lining, an antibiotic to kill bacteria, and an enzyme to break up thick mucus. 108 participants will use the spray twice daily for…

This study tests a new gel that slowly releases medicine to treat advanced gum disease (periodontitis). The gel is placed directly into deep gum pockets to fight infection, reduce swelling, and help bone grow back. Researchers will study 80 people with severe gum disease to see i…

This study tests an injectable gel containing a bone-growth protein (BMP-2) to help regrow bone damaged by severe gum disease. The gel is designed to fight bacteria, reduce inflammation, and promote bone repair. Researchers will enroll 80 people with advanced periodontitis and bo…

This study tests a new silk-reinforced collagen membrane designed to help regrow bone in the jaw for people with advanced gum disease (periodontitis). The membrane is placed during a dental procedure to guide bone regeneration. Researchers will measure bone fill and density using…

This study tests whether stem cells taken from donated teeth can be safely injected into the gums to treat periodontitis, a serious gum infection that damages tissue and bone. The goal is to help regrow lost gum and bone without the need for traditional surgery. The trial will en…

This early study is testing a new dressing made from sodium hyaluronate and carbomer hydrogel for first and shallow second-degree burns. The goal is to see if it helps the burn heal completely within 50 days and reduces itching. The study will involve 30 adults with burn wounds o…

This early-stage trial is testing whether adding oral serine, a natural amino acid, to standard chemotherapy is safe for people with advanced colorectal cancer. The study will enroll 20 adults who are eligible for first-line treatment with fluorouracil-based drugs. The main goal …

This early study tests a new gel for melasma, a skin condition causing dark patches on the face. The gel combines three ingredients to lighten spots, reduce inflammation, and help absorption. Ten women aged 18-50 will apply the gel for 12 weeks to see if it improves their skin wi…

This study tests whether a new drug combination (anricofen plus ciprofol) can provide safer deep sedation for elderly patients undergoing ERCP, a procedure to treat bile duct problems. The goal is to reduce breathing complications and speed up recovery compared to the standard se…

This study compares a newer anesthesia drug, remimazolam, with the standard drug propofol (both combined with a painkiller) for people having chest surgery. The goal is to see if remimazolam causes fewer problems like low oxygen levels or low blood pressure during the operation. …

This early-phase study tests whether adding malic acid (a natural fruit acid) to standard immunotherapy is safe for people with solid tumors like colorectal, lung, or melanoma cancer. About 30 participants will take malic acid by mouth while continuing their immunotherapy. The ma…

This study looks for biological markers in tumor tissue and blood that may be linked to anxiety and depression in people with solid tumors. Researchers will combine psychological assessments with lab tests to better understand these emotional struggles. The goal is to improve ear…